phase 1a study for healthy normals
Showing 1 - 25 of >10,000
Healthy Subjects Trial in Christchurch (EC5026 oral tablet, Placebo oral tablet)
Not yet recruiting
- Healthy Subjects
- EC5026 oral tablet
- Placebo oral tablet
-
Christchurch, New ZealandNew Zealand Clinical Research
Oct 17, 2023
Ulcerative Colitis Trial in Melbourne (LIV001, Placebo)
Not yet recruiting
- Ulcerative Colitis
- LIV001
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Jul 26, 2023
Hemophilia A, Hemophilia B, Blood Coagulation Disorders Trial in Seoul (TU7710, Normal saline)
Recruiting
- Hemophilia A
- +2 more
- TU7710
- Normal saline
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 8, 2023
Alzheimer's Disease Trial (CS6253 Solution for Injection, Placebo)
Not yet recruiting
- Alzheimer's Disease
- CS6253 Solution for Injection
- Placebo
- (no location specified)
Jul 20, 2023
Cystic Fibrosis Trial in Christchurch (ABCI, Placebo)
Recruiting
- Cystic Fibrosis
- ABCI
- Placebo
-
Christchurch, New ZealandNew Zealand Clinical Research
Apr 4, 2023
Healthy Trial in Christchurch (LTG-001, Placebo)
Not yet recruiting
- Healthy
- LTG-001
- Placebo
-
Christchurch, New ZealandClinical Research Unit
Sep 21, 2023
Healthy Trial in Madison (Fadraciclib)
Active, not recruiting
- Healthy
-
Madison, WisconsinLabcorp Clinical Research Unit
Apr 5, 2023
Healthy Volunteers Trial in Melbourne (Verasone)
Not yet recruiting
- Healthy Volunteers
-
Melbourne, Victoria, AustraliaNucleus Network
Nov 19, 2023
Healthy Adult Subjects Trial in Seoul (ID110521156, Placebo of ID110521156)
Not yet recruiting
- Healthy Adult Subjects
- ID110521156
- Placebo of ID110521156
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 26, 2023
Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)
Not yet recruiting
- Healthy
- Daridorexant 10 mg
- Daridorexant 25 mg
- (no location specified)
Jun 1, 2023
Ischemia-reperfusion Injury Trial in Adelaide (BX-001N Part 1, BX-001N Part 2, Placebo)
Not yet recruiting
- Ischemia-reperfusion Injury
- BX-001N Part 1
- +2 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Oct 19, 2023
Healthy Trial in Madison (LY3502970, [14C]-LY3502970)
Not yet recruiting
- Healthy
-
Madison, WisconsinCovance Clinical Research Inc
Oct 10, 2023
Opioid Overdose, Opioid Use Disorder Trial in Overland Park (CSX-1004, Placebo)
Recruiting
- Opioid Overdose
- Opioid Use Disorder
- CSX-1004
- Placebo
-
Overland Park, KansasDr. Vince Clinical Research
Aug 17, 2023
Nonalcoholic Steatohepatitis Trial in Taipei (HUYPS-1 one tablet, HUYPS-1 nine tablets)
Completed
- Nonalcoholic Steatohepatitis
- HUYPS-1 one tablet
- HUYPS-1 nine tablets
-
Taipei, TaiwanTri-Service General Hospital
Aug 1, 2023
Thrombosis Trial in Perth (SRSD107, Placebo)
Not yet recruiting
- Thrombosis
- SRSD107
- Placebo
-
Perth, Other (Non U.s.), AustraliaLinear Clinical Research
Nov 2, 2023
Parkinson Disease Psychosis, Amyotrophic Lateral Sclerosis (ALS) Trial (FB418)
Not yet recruiting
- Parkinson Disease Psychosis
- Amyotrophic Lateral Sclerosis (ALS)
- (no location specified)
Aug 13, 2023
Chikungunya Virus Infection Trial (VLA1553 full dose, VLA1553 half dose, Control)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553 full dose
- +2 more
- (no location specified)
Oct 24, 2023
Healthy Subjects Trial in Melbourne (AP301)
Not yet recruiting
- Healthy Subjects
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Oct 20, 2023
Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)
Not yet recruiting
- Chronic Hepatitis B
- HEPLISAV B; TherVacB
- TherVacB
-
Hamburg, GermanyCTC North
Feb 3, 2023
Healthy Trial in Adelaide (XH-S003 (A), Placebo (B))
Not yet recruiting
- Healthy
- XH-S003 (A)
- Placebo (B)
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 21, 2023